(Q82488232)
Statements
Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML) (English)
Brenner MK
Heslop HE
Durett A
May R
Krance RA